These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma. Tamura S; Nakamori S; Kuroki T; Sasaki Y; Furukawa H; Ishikawa O; Imaoka S; Nakamura Y J Hepatol; 1997 Oct; 27(4):669-76. PubMed ID: 9365043 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978 [TBL] [Abstract][Full Text] [Related]
14. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Abraham SC; Wu TT; Hruban RH; Lee JH; Yeo CJ; Conlon K; Brennan M; Cameron JL; Klimstra DS Am J Pathol; 2002 Mar; 160(3):953-62. PubMed ID: 11891193 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal instability and human hepatocarcinogenesis. Nishida N; Nishimura T; Ito T; Komeda T; Fukuda Y; Nakao K Histol Histopathol; 2003 Jul; 18(3):897-909. PubMed ID: 12792902 [TBL] [Abstract][Full Text] [Related]
16. Multiple chromosomal abnormalities in human liver (pre)neoplasia. Raidl M; Pirker C; Schulte-Hermann R; Aubele M; Kandioler-Eckersberger D; Wrba F; Micksche M; Berger W; Grasl-Kraupp B J Hepatol; 2004 Apr; 40(4):660-8. PubMed ID: 15030983 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
18. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783 [TBL] [Abstract][Full Text] [Related]
19. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Wong CM; Fan ST; Ng IO Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619 [TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Buendia MA Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]